Weinberger M H
Department of Medicine, Indiana University School of Medicine, Indianapolis 46223.
J Cardiovasc Pharmacol. 1989;13 Suppl 3:S1-4. doi: 10.1097/00005344-198900133-00002.
Angiotensin converting enzyme (ACE) inhibition has provided a new approach to the treatment of hypertension. The broad efficacy of ACE inhibitors across the entire spectrum of hypertension exceeds original predictions. Diuretics have been shown to extend efficacy to over 85% of noncomplicated hypertensives. In addition to efficacy, combination of ACE inhibitors with diuretics permits prevention or attenuation of many undesirable side effects of diuretic therapy, including hypokalemia, hyperuricemia, hyperglycemia, and hypercholesterolemia. Thus, considerations of both efficacy and beneficial effects on cardiovascular disease risk factors make the combination of ACE inhibitors and diuretics an attractive one in the treatment of hypertension.
血管紧张素转换酶(ACE)抑制剂为高血压治疗提供了一种新方法。ACE抑制剂在整个高血压范围内的广泛疗效超出了最初的预期。利尿剂已被证明可将疗效扩展至超过85%的非复杂性高血压患者。除疗效外,ACE抑制剂与利尿剂联合使用可预防或减轻利尿剂治疗的许多不良副作用,包括低钾血症、高尿酸血症、高血糖和高胆固醇血症。因此,考虑到疗效以及对心血管疾病危险因素的有益影响,ACE抑制剂与利尿剂联合使用在高血压治疗中颇具吸引力。